Your browser doesn't support javascript.
loading
ACTIV-2: A Platform Trial for the Evaluation of Novel Therapeutics for the Treatment of Early COVID-19 in Outpatients.
Currier, Judith S; Moser, Carlee; Eron, Joseph J; Chew, Kara W; Smith, Davey M; Javan, Arzhang Cyrus; Wohl, David Alain; Daar, Eric S; Hughes, Michael D.
Afiliação
  • Currier JS; Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California, USA.
  • Moser C; Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
  • Eron JJ; Department of Medicine, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.
  • Chew KW; Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California, USA.
  • Smith DM; Department of Medicine, University of California, San Diego, La Jolla, California, USA.
  • Javan AC; Division of AIDS, National Institutes of Health, Rockville, Maryland, USA.
  • Wohl DA; Department of Medicine, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.
  • Daar ES; Lundquist Institute at Harbor-UCLA Medical Center, Torrance, California, USA.
  • Hughes MD; Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
J Infect Dis ; 228(Suppl 2): S77-S82, 2023 08 31.
Article em En | MEDLINE | ID: mdl-37650231
Clinical Trials Registration ClinicalTrials.gov Identifier: NCT04518410.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pacientes Ambulatoriais / COVID-19 Limite: Humans Idioma: En Revista: J Infect Dis Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pacientes Ambulatoriais / COVID-19 Limite: Humans Idioma: En Revista: J Infect Dis Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos